The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $16.88

Today's change-0.23 -1.32%
Updated January 17 3:28 PM EST. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $16.88

Today's change-0.23 -1.32%
Updated January 17 3:28 PM EST. Delayed by at least 15 minutes.

Meridian Bioscience Inc down (U.S.)$0.23

Meridian Bioscience Inc is lower today, dropping (U.S.)$0.23 or 1.32% to (U.S.)$16.88. Over the last five days, shares have lost 3.02% and 7.99% over the last 52 weeks. This security has underperformed the S&P 500 by 28.39% during the last year.

Key company metrics

  • Open(U.S.) $16.95
  • Previous close(U.S.) $17.10
  • High(U.S.) $17.10
  • Low(U.S.) $16.80
  • Bid / Ask(U.S.) $16.85 / (U.S.) $16.90
  • YTD % change-4.66%
  • Volume178,211
  • Average volume (10-day)270,815
  • Average volume (1-month)301,098
  • Average volume (3-month)265,100
  • 52-week range(U.S.) $15.75 to (U.S.) $21.49
  • Beta1.05
  • Trailing P/E22.21×
  • P/E 1 year forward20.85×
  • Forward PEG1.23×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield4.74%
  • Trailing EPS(U.S.) $0.76
Updated January 17 3:28 PM EST. Delayed by at least 15 minutes.
S&P TSX0.24%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue47515147
Total other revenue--------
Total revenue47515147
Gross profit30333432
Total cost of revenue17181816
Total operating expense38373634
Selling / general / administrative16161515
Research & development4433
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)10----
Other operating expenses, total--------
Operating income9141514
Interest income (expense), net non-operating000--
Gain (loss) on sale of assets--------
Other--------
Income before tax9131514
Income after tax5999
Income tax, total3565
Net income5999
Total adjustments to net income--------
Net income before extra. items5999
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5999
Inc. avail. to common incl. extra. items5999
Diluted net income5999
Dilution adjustment----0--
Diluted weighted average shares42424242
Diluted EPS excluding extraordinary itemsvalue per share0.130.210.210.21
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.140.210.210.21